Ryght AI to Showcase AI-Powered Clinical Research Platform as Featured Solution Partner in Microsoft Booth at HLTH 2025

Live Demonstrations of AI Site Twin Technology to Highlight How Advanced AI is Transforming Clinical Trial Timelines

LAGUNA BEACH, Calif., Oct. 6, 2025 /PRNewswire/ -- Ryght AI, the intelligent platform transforming clinical trial execution through AI Site Twin technology, today announced it will be a featured partner in the Microsoft Booth (#3860, Level 2, AI Zone) at HLTH 2025 in Las Vegas from October 19-22. Healthcare leaders, sponsors, and CROs attending the premier health innovation conference will have the opportunity to experience live demonstrations of Ryght's advanced generative AI platform and discover how AI is revolutionizing site selection, feasibility, and study operations.

HLTH 2025 brings together over 12,000 influential healthcare leaders, executives, and visionaries to explore cutting-edge innovations shaping the future of healthcare. Ryght's presence in the Microsoft Booth underscores the growing momentum of AI-driven solutions in clinical research, particularly following the company's recent availability in Microsoft Azure Marketplace.

"HLTH represents a unique opportunity to connect with healthcare innovators who are actively seeking solutions to accelerate clinical trial timelines," said Simon Arkell, CEO and Co-Founder of Ryght AI. "Our partnership with Microsoft and integration into both the Microsoft and Azure Marketplaces has already opened new doors for sponsors and CROs looking to leverage their existing cloud investments while adopting cutting-edge AI technology. We're excited to demonstrate how our platform built on AI Site Twins is helping organizations get treatments to patients faster, while reducing costs and operational complexity."

Ryght's platform features AI Site Twins, which are dynamic digital models of every clinical research site globally. Each AI Site Twin captures the individual operational characteristics, historical trial performance, PI expertise, and regulatory history of each individual clinical research site. This innovative approach enables sponsors and CROs to automate traditionally manual processes, with organizations experiencing up to 60% reductions in trial start-up timelines. By eliminating time-consuming site identification and feasibility workflows, Ryght helps advance programs to market faster, translating saved time into millions of dollars in extended market exclusivity.

The live demonstrations at HLTH will showcase how Ryght's AI-powered platform brings significant improvements in study startup and execution across multiple categories, including:

• Reduced Delays: Faster site startup through intelligent automation and comprehensive site prequalification
  
  
• Enhanced Accuracy: More precise enrollment forecasting and budget modeling reduce financial risk
  
  
• Cost Optimization: Decreased risk of mid-trial delays, costly amendments, rescue strategies and cost overruns through better upfront planning
  
  
• Improved Efficiency: Streamlined site engagement with direct communication to high-fit, high-capacity research partners

Attendees can visit Ryght in the Microsoft Booth #3860 on Level 2 in the AI Zone throughout the conference to experience personalized demonstrations and discuss how AI Site Twins can transform their clinical research operations. To book a personalized demo, please visit https://www.ryght.ai/hlth2025

Ryght's recent integration into Microsoft Azure Marketplace enables healthcare organizations to leverage existing Azure cloud commitments while accessing advanced AI capabilities. The SOC Type 2-compliant platform also enhances efficiency through seamless, real-time communication between sponsors, CROs, and research sites.

For more information about Ryght at HLTH 2025 or to schedule a personalized demo, please visit https://www.ryght.ai/hlth2025 or stop by the Microsoft Booth #3860.

About Ryght:
 Ryght AI is transforming clinical trial timelines with a cutting-edge intelligent platform powered by AI Site Twins, which are dynamic data models representing every clinical research site in the world. This innovative approach empowers sponsors and CROs to significantly accelerate clinical trial study startup through faster site selection and streamlined feasibility workflows, all powered by advanced generative and agentic AI. Furthermore, Ryght's SOC Type 2-compliant platform enhances efficiency by fostering seamless, real-time communication between sponsors, CROs, and research sites.

For more information, please visitwww.ryght.ai. To discuss AI-powered clinical trial solutions or network membership for your site, CRO or sponsor company, please email [email protected].

Media Contact:
Ariel Paradis
[email protected]

SOURCE Ryght